Triple negative breast cancer–prognostic role of immune-related factors: a systematic review

ES Stovgaard, D Nielsen, E Hogdall, E Balslev - Acta Oncologica, 2018 - Taylor & Francis
Purpose: Treatment of breast cancer has been increasingly successful in recent years with
the advent of HER2-receptor targeted treatment and endocrine treatment. However, the …

ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells

J Faget, N Bendriss-Vermare, M Gobert, I Durand… - Cancer research, 2012 - AACR
Human breast tumors are infiltrated by memory CD4+ T cells along with increased numbers
of regulatory T cells (Treg) and plasmacytoid dendritic cells (pDC) that facilitate immune …

Plasmacytoid dendritic cells recruited by HIF-1α/eADO/ADORA1 signaling induce immunosuppression in hepatocellular carcinoma

L Pang, KTP Ng, J Liu, WHO Yeung, J Zhu, TLS Chiu… - Cancer Letters, 2021 - Elsevier
Plasmacytoid dendritic cells (pDCs) play immunosuppressive roles in the tumor
microenvironment (TME). However, the molecular mechanisms underlying the recruitment …

[HTML][HTML] Recruitment and expansion of tregs cells in the tumor environment—how to target them?

J Cinier, M Hubert, L Besson, A Di Roio, C Rodriguez… - Cancers, 2021 - mdpi.com
Simple Summary The immune response against cancer is generated by effector T cells,
among them cytotoxic CD8+ T cells that destroy cancer cells and helper CD4+ T cells that …

[HTML][HTML] STAT3 interactors as potential therapeutic targets for cancer treatment

F Laudisi, F Cherubini, G Monteleone… - International journal of …, 2018 - mdpi.com
Signal transducers and activators of transcription (STATs) mediate essential signaling
pathways in different biological processes, including immune responses, hematopoiesis …

[HTML][HTML] Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Q Lan, S Peyvandi, N Duffey, YT Huang, D Barras… - Oncogene, 2019 - nature.com
Neoadjuvant and adjuvant chemotherapies provide survival benefits to breast cancer
patients, in particular in estrogen receptor negative (ER−) cancers, by reducing rates of …

[HTML][HTML] Type I interferon production of plasmacytoid dendritic cells under control

D Bencze, T Fekete, K Pázmándi - International journal of molecular …, 2021 - mdpi.com
One of the most powerful and multifaceted cytokines produced by immune cells are type I
interferons (IFNs), the basal secretion of which contributes to the maintenance of immune …

[HTML][HTML] Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer

Y Lin, X Jing, Z Chen, X Pan, D Xu, X Yu, F Zhong… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: Studies have shown that the expression of histone deacetylases (HDACs) is
significantly related to the tumor microenvironment (TME) in gastric cancer. However, the …

Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL

C Aspord, MT Leccia, J Charles, J Plumas - Cancer immunology research, 2013 - AACR
Even though melanoma is considered to be one of the most immunogenic solid tumors,
handling its development remains a challenge. The basis for such escape from antitumor …

[HTML][HTML] A characterization of dendritic cells and their role in immunotherapy in glioblastoma: from preclinical studies to clinical trials

S Srivastava, C Jackson, T Kim, J Choi, M Lim - Cancers, 2019 - mdpi.com
Glioblastoma (GBM) is the most common and fatal primary central nervous system
malignancy in adults with a median survival of less than 15 months. Surgery, radiation, and …